Skip to main content
SpringerLink
Log in

IAPP boosts islet macrophage IL-1 in type 2 diabetes

  • News & Views
  • Published:

From Nature Immunology

View current issue Submit your manuscript

A Corrigendum to this article was published on 15 February 2011

This article has been updated

IAPP, a hormone secreted together with insulin and deposited in pancreatic islets in type 2 diabetes, can induce macrophage processing of interleukin 1 linked to beta-cell destruction in type 2 diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: The beta cell in type 2 diabetes: under fire from friend and foe.

Change history

  • 21 October 2010

    In the version of this article initially published, some of the text on p 882 was inaccurate. The correct text should read as follows: “thereby counteracting the beneficial effects of blocking IAPP on islet inflammation” (middle column) and “This mechanism has been suggested to mediate ROS-dependent inflammasome activation induced by high concentrations of glucose in mouse pancreatic beta cells12, although this finding is now being debated” (right column, first full paragraph, second sentence). The errors have been corrected in the HTML and PDF versions of the article.

References

  1. Kolb, H. & Mandrup-Poulsen, T. Diabetologia 48, 1038–1050 (2005).

    Article  CAS  PubMed  Google Scholar 

  2. Dinarello, C.A. Annu. Rev. Immunol. 27, 519–550 (2009).

    Article  CAS  PubMed  Google Scholar 

  3. Kastner, D.L., Aksentijevich, I. & Goldbach-Mansky, R. Cell; 140, 784–790 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Goldfine, A.B. et al. Ann. Intern. Med. 152, 346–357 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Larsen, C.M. et al. N. Engl. J. Med. 356, 1517–1526 (2007).

    Article  CAS  PubMed  Google Scholar 

  6. Evans, J.L. et al. Diabetes 52, 1–8 (2003).

    Article  CAS  PubMed  Google Scholar 

  7. Westermark, P. et al. Proc. Natl. Acad. Sci. USA 84, 3881–3885 (1987).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dinarello, C.A., Donath, M.Y. & Mandrup-Poulsen, T. Curr. Opin. Endocrinol. Diab. (in the press).

  9. Mandrup-Poulsen, T., Pickersgill, L.M.S. & Donath, M.Y. Nat. Rev. Endocrinol. 6, 158–166 (2010).

    Article  CAS  PubMed  Google Scholar 

  10. Masters, S.L. et al. Nat. Immunol. 11, 897–904 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Maedler, K. et al. Diabetes 53, 1706–1713 (2004).

    Article  CAS  PubMed  Google Scholar 

  12. Zhou, R. et al. Nat. Immunol. 11, 136–140 (2010).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thomas Mandrup-Poulsen is in the Department for Biomedical Sciences, Denmark and the Department of Medicine and Surgery, University of Copenhagen, Copenhagen, the Hagedorn Research Institute, Gentofte, Karolinska Institutet, Stockholm, Sweden.,

    Thomas Mandrup-Poulsen

Authors
  1. Thomas Mandrup-Poulsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Mandrup-Poulsen.

Ethics declarations

Competing interests

T.M.-P. is a part-time employee of and owns shares in Novo Nordisk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mandrup-Poulsen, T. IAPP boosts islet macrophage IL-1 in type 2 diabetes. Nat Immunol 11, 881–883 (2010). https://doi.org/10.1038/ni1010-881

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni1010-881

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation